MarketLine Blog

Posts about Healthcare

Cannabis market: Aurora Cannabis leading the market

MarketLine

Quite a few countries before Canada had legalized recreational marijuana use, or enacted laws partially allowing it. However, none of those countries created a legal market for marijuana. For a market to emerge it has to be backed by serious economic and political power; Canada is just such a country. On October 17th 2018 the Canadian parliament approved the Cannabis Act, giving the green light for using and growing marijuana and initiating the process for a market to emerge. The creation of companies specializing in producing marijuana for recreational purposes… Read more

Weight Watchers: A poorly timed rebranding has crushed investor expectations and collapsed the share price

MarketLine

On February 26th 2019, dieting and weight-loss company Weight Watchers released its annual report for 2018. The share price settled in the week following the announcement, but not before the company suffered the second-largest share price drop in its history, dropping nearly 35% overnight. While the financial performance was remarkable – revenues and operating incomes grew more than $200m and $100m respectively – investors were primarily interested in what is perhaps Weight Watchers’ most important metric: its number of end of period subscribers. Historically Weight Watchers has found subscribers following… Read more

UK sugar tax – Attempts to curb rising levels of obesity

MarketLine

The UK is the most obese country in Western Europe, and the sixth most obese country in the world. Around 26.9% of the British population has a body mass index of 30 and above, according to the OECD report and the cost of treating ill health caused by obesity and related issues is rising fast, threatening the NHS budget. The government, long criticized for taking no action to tackle this issue, decided to introduce a Soft Drinks Industry Levy, in the hope that the increased cost will stop people from… Read more

Norway & Drugs: Scandinavian country moves to decriminalize illicit drugs, rest of Europe likely to follow eventually

MarketLine

In a first for Scandinavian countries, but unlikely to be the last, Norway has moved to decriminalize the use of illicit drugs. Whilst this is just the starting point for the process of decriminalization and the government still needs to implement the directives from parliament with coherent public policy, the vote represents the current wind of change. In Europe the move towards decriminalization of illicit drugs is an awkward topic; many different countries view this change as a backwards step and even those countries which have pioneered new ways of… Read more

CRISPR Gene Editing: Now the technology is being used on humans, we can and should change the nature of our species

MarketLine

CRISPR technology is a simple yet incredibly powerful tool for editing genomes, the fundamental building blocks of any organism. It allows researchers to easily alter DNA sequences and modify gene function potentially with no limits or boundaries to what can be done to alter the physical attributes of animals and human beings. The process uses enzymes to cut through sections of DNA allowing new sequences to be added or parts removed. The result is that we can now completely alter genes, therefore the actual structure of an organism itself. Perfected… Read more

Beyond the pill: Pharma gets digital push

MarketLine

The global pharmaceutical market was worth $946.1bn in 2016, growing with a compound annual growth rate (CAGR) of 6.1% between 2012 and 2016. Healthy market growth and big margins in the traditional pharma industry are attracting a new generation of startup companies, who are using big data, sensors and artificial intelligence to revolutionize the way healthcare is delivered and they are not afraid to compete with the incumbent Big Pharma companies. Emerging digital technologies from the new generation start-ups are reshaping the traditional pharma landscape. By collecting enough data, directly… Read more

Gene Editing: Bring your genome home

MarketLine

In recent years, two new genetic technologies have started a scientific and medical revolution. One is the ability to easily decode the information in our genes and it is relatively well known. It began with the development of tests for genetic diseases. They have proven they can be quite successful, leading to a reduction of human suffering. The other, not yet clearly understood by the general public, is the newfound capacity to modify genes at will. New editing tools to create genetically defined human cell lines have come to the… Read more

Medical Devices: Strong technological innovation is driving the industry, but it creates new vulnerabilities too

MarketLine

The medical device market is growing well and has been posting consistent and stable revenues for a number of years and some market segments are even achieving double digit growth rates. The market is doing so well because the rate of innovation in new products is allowing treatments that were previously unthinkable; devices that can allow patients to see, walk or hear again for instance. These new types of devices may provide solutions for some of the most unsolvable medical problems over the next decade and this means the health… Read more

Sequencing Quinoa: Food for thought

MarketLine

The pharmaceutical industry has been growing at a strong rate in recent years. One aspect of this market is that of the food supplement. The growing trend especially amongst the older populace and with the hectic lifestyles that are led in developed countries lends support to the supplement industry. The ability of scientists to understand the functions of different genes have assisted in the growth of specific markets and also in the changes to specific plant species. When looking at some of the historic plant species and how they have… Read more

Global healthcare expenditure to hit $9.17 trillion by 2020 as US market burgeons, says MarketLine

MarketLine

Global healthcare expenditure is set to grow from just over $7.2 trillion in 2015 to around $9.17 trillion by 2020, registering a compound annual growth rate (CAGR) of 5%, according to research firm MarketLine. The company’s report states that growth will primarily be driven by the US, which dominates the global market and accounts for nearly 50% of total expenditure. The country also has a good forecast CAGR of 4.6%, exceeding that of Europe and Asia-Pacific, indicating that its share of the healthcare market will rise by 2020. Kate Moody,… Read more

Brexit and Trump’s disastrous effect on science

MarketLine

2016 has been a rollercoaster of a year with regards to political incidences. With the UK voting in favor of leaving the EU in June 2016 and then a follow up of the US voting for President-elect Donald Trump in November of the same year, this has led to a degree of uncertainty in the scientific field. With funding at the forefront of scientific research and the advancement of scientific breakthroughs, the future has been thrown into turmoil as the individuals working in both countries, the US and the UK,… Read more